documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
48 rows where docket_id = "FDA-1994-N-0182" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1994-N-0182-0048 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | Transcript of the Pubic Hearing on Acyclovir - Transcript | Other | TR-Transcript | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2008-12-23T21:01:45Z | 0 | 0 | 090000648070b75e | ||
| FDA-1994-N-0182-0009 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | FDA "Dear Colleague" Letter | Other | LET-Letter | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2008-12-23T21:01:01Z | 0 | 0 | 090000648050714a | ||
| FDA-1994-N-0182-0027 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | Harvard Medical School - Appearance Request | Other | APE-Appearance Request | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2008-12-23T21:01:21Z | 0 | 0 | 0900006480507164 | ||
| FDA-1994-N-0182-0022 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | Association of Reproductive Professional - Supplement | Other | SUP-Supplement | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2008-12-23T21:01:15Z | 0 | 0 | 090000648050715e | ||
| FDA-1994-N-0182-0005 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | Distribution of FR Notice for Acyclovir Public Hearing - Memorandum | Other | M-Memorandum | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2008-12-23T21:00:57Z | 0 | 0 | 0900006480507146 | ||
| FDA-1994-N-0182-0040 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | American Social Health Association - Testimony | Other | TS-Testimony | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2013-08-11T02:40:17Z | 0 | 0 | 0900006480507187 | ||
| FDA-1994-N-0182-0003 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | FDA "Dear Colleague" Letter | Other | LET-Letter | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2008-12-23T21:00:54Z | 0 | 0 | 0900006480507144 | ||
| FDA-1994-N-0182-0046 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | HFD-9 - Memorandum | Other | M-Memorandum | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2008-12-23T21:01:43Z | 0 | 0 | 09000064805071be | ||
| FDA-1994-N-0182-0013 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | Denise M. Buntin, M.D. - Appearance Request | Other | APE-Appearance Request | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2013-08-11T02:40:16Z | 0 | 0 | 0900006480507150 | ||
| FDA-1994-N-0182-0020 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | American Academy of Dermatology - Appearance Request | Other | APE-Appearance Request | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2013-07-27T21:20:30Z | 0 | 0 | 090000648050715a | ||
| FDA-1994-N-0182-0031 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | Nonprescription Drug Manufacturers Assn. - Appearance Request | Other | APE-Appearance Request | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2008-12-23T21:01:26Z | 0 | 0 | 090000648050716f | ||
| FDA-1994-N-0182-0030 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | Center for Disease Control and Prevention - Appearance Request | Other | APE-Appearance Request | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2008-12-23T21:01:25Z | 0 | 0 | 090000648050716e | ||
| FDA-1994-N-0182-0049 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | Index - List | Other | LST-List | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2008-12-23T21:01:47Z | 0 | 0 | 090000648070b89e | ||
| FDA-1994-N-0182-0018 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | National Women's Health Network - Appearance Request | Other | APE-Appearance Request | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2013-07-27T21:20:30Z | 0 | 0 | 0900006480507156 | ||
| FDA-1994-N-0182-0026 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | Infectious Diseases Society of America - Appearance Request | Other | APE-Appearance Request | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2008-12-23T21:01:20Z | 0 | 0 | 0900006480507163 | ||
| FDA-1994-N-0182-0007 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | Distribution of FR Notice for Acyclovir Public Hearing - Memorandum | Other | M-Memorandum | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2008-12-23T21:00:59Z | 0 | 0 | 0900006480507148 | ||
| FDA-1994-N-0182-0006 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | FDA "Dear Colleague" Letter | Other | LET-Letter | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2008-12-23T21:00:58Z | 0 | 0 | 0900006480507147 | ||
| FDA-1994-N-0182-0044 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | Harvard Medical School - Letter | Other | LET-Letter | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2008-12-23T21:01:41Z | 0 | 0 | 09000064805071aa | ||
| FDA-1994-N-0182-0019 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | University of Kansas Medical Center - Appearance Request | Other | APE-Appearance Request | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2013-07-27T21:20:30Z | 0 | 0 | 0900006480507157 | ||
| FDA-1994-N-0182-0015 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | The Center for Proper Medication Use - Appearance Request | Other | APE-Appearance Request | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2013-07-27T21:20:30Z | 0 | 0 | 0900006480507152 | ||
| FDA-1994-N-0182-0042 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | HFD-336 - Memorandum | Other | M-Memorandum | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2008-12-23T21:01:39Z | 0 | 0 | 0900006480507198 | ||
| FDA-1994-N-0182-0017 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | University of Pittsburgh - Appearance Request | Other | APE-Appearance Request | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2013-07-27T21:20:30Z | 0 | 0 | 0900006480507154 | ||
| FDA-1994-N-0182-0032 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | Denise M. Buntin, M.D., P.C - Wthdrawal | Other | WDL-Withdrawal | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2013-07-27T21:20:30Z | 0 | 0 | 0900006480507171 | ||
| FDA-1994-N-0182-0021 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | Infectious Diseases Society for Ob-Gyn - Appearance Request | Other | APE-Appearance Request | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2013-07-27T21:20:30Z | 0 | 0 | 090000648050715b | ||
| FDA-1994-N-0182-0033 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | HFD-9 - List | Other | LST-List | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2008-12-23T21:01:29Z | 0 | 0 | 0900006480507173 | ||
| FDA-1994-N-0182-0045 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | HFD-9 - List | Other | LST-List | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2008-12-23T21:01:42Z | 0 | 0 | 09000064805071ab | ||
| FDA-1994-N-0182-0014 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | FDA "Dear Colleague" Letter | Other | LET-Letter | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2008-12-23T21:01:07Z | 0 | 0 | 0900006480507151 | ||
| FDA-1994-N-0182-0034 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | Nonprescription Drug Manufacturers Assn. - Testimony | Other | TS-Testimony | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2013-07-27T21:20:30Z | 0 | 0 | 0900006480507181 | ||
| FDA-1994-N-0182-0039 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | American Medical Women's Association - Testimony | Other | TS-Testimony | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2013-07-27T21:20:31Z | 0 | 0 | 0900006480507186 | ||
| FDA-1994-N-0182-0012 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | Association of Reproductive Health Professionals - Appearance Request | Other | APE-Appearance Request | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2013-07-28T01:40:44Z | 0 | 0 | 090000648050714f | ||
| FDA-1994-N-0182-0010 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | University of Washington School of Medicine - Appearance Request | Other | APE-Appearance Request | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2013-07-27T21:20:29Z | 0 | 0 | 090000648050714b | ||
| FDA-1994-N-0182-0001 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | Proposed Switch of Acyclovir from Prescription to Over-the-Counter Status; Public Hearing - Notice of Hearing Before the Commissioner | Notice | NHC-Notice of Hearing Before Commissioner | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 1994-06-21T03:59:59Z | 2008-12-23T21:00:51Z | 0 | 0 | 0900006480507142 | |
| FDA-1994-N-0182-0002 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | Joint Meeting of the Antiviral Drugs and Nonprescription Drugs Advisory Committees - Notice of Meeting | Notice | NM-Notice of Meeting | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2008-12-23T21:00:52Z | 0 | 0 | 0900006480507143 | ||
| FDA-1994-N-0182-0016 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | American Society of Hospital Pharmacists - Appearance Request | Other | APE-Appearance Request | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2013-07-28T01:40:44Z | 0 | 0 | 0900006480507153 | ||
| FDA-1994-N-0182-0025 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | HFD-9 - List | Other | LST-List | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2008-12-23T21:01:19Z | 0 | 0 | 0900006480507162 | ||
| FDA-1994-N-0182-0035 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | American Academy of Dermatology - Testimony | Other | TS-Testimony | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2013-07-27T21:20:31Z | 0 | 0 | 0900006480507182 | ||
| FDA-1994-N-0182-0036 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | Assn. of Reproductive Health Professionals - Testimony | Other | TS-Testimony | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2013-07-28T01:40:45Z | 0 | 0 | 0900006480507183 | ||
| FDA-1994-N-0182-0028 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | Center for Proper Medication Use - Appearance Request | Other | APE-Appearance Request | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2008-12-23T21:01:22Z | 0 | 0 | 090000648050716b | ||
| FDA-1994-N-0182-0008 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | FDA "Dear Colleague" Letter | Other | LET-Letter | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2008-12-23T21:01:00Z | 0 | 0 | 0900006480507149 | ||
| FDA-1994-N-0182-0023 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | NANPRH - Supplement | Other | SUP-Supplement | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2008-12-23T21:01:17Z | 0 | 0 | 0900006480507160 | ||
| FDA-1994-N-0182-0024 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | American Medical Association - Appearance Request | Other | APE-Appearance Request | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2013-08-11T04:13:53Z | 0 | 0 | 0900006480507161 | ||
| FDA-1994-N-0182-0043 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | HFD-9 - Letter | Other | LET-Letter | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2008-12-23T21:01:40Z | 0 | 0 | 09000064805071a6 | ||
| FDA-1994-N-0182-0029 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | HFD-9 - List | Other | LST-List | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2008-12-23T21:01:23Z | 0 | 0 | 090000648050716c | ||
| FDA-1994-N-0182-0037 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | Center for Proper Medication Use - Testimony | Other | TS-Testimony | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2013-07-27T21:20:31Z | 0 | 0 | 0900006480507184 | ||
| FDA-1994-N-0182-0038 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | American Society of Hospital Pharmacists - Testimony | Other | TS-Testimony | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2013-07-27T21:20:31Z | 0 | 0 | 0900006480507185 | ||
| FDA-1994-N-0182-0047 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | HFD-9 - Memorandum of Meeting | Other | MM-Memorandum of Meeting | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2008-12-23T21:01:44Z | 0 | 0 | 09000064805071c1 | ||
| FDA-1994-N-0182-0041 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | Univeristy of Florida - Supplement | Other | SUP-Supplement | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2008-12-23T21:01:38Z | 0 | 0 | 0900006480507193 | ||
| FDA-1994-N-0182-0011 | FDA | Proposed Switch of Acyclovir from Prescription to OTC Status FDA-1994-N-0182 | National Association of Nurse Practitioners in Reproductive Health - Appearance Request | Other | APE-Appearance Request | 2008-12-23T05:00:00Z | 2008 | 12 | 2008-12-23T05:00:00Z | 2013-07-27T21:20:29Z | 0 | 0 | 090000648050714e |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);